BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 19837757)

  • 21. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
    Sato M; Okumura T; Kaito K; Kiyoshima M; Asato Y; Uchiumi K; Iijima H; Hashimoto I; Kaburagi T; Amemiya R
    Ann Nucl Med; 2009 Jan; 23(1):49-57. PubMed ID: 19205838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation.
    Roedl JB; Colen RR; Holalkere NS; Fischman AJ; Choi NC; Blake MA
    Radiother Oncol; 2008 Dec; 89(3):278-86. PubMed ID: 18701180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation between FDG PET /CT and the expression of glutl and ki-67 antigen in esophageal cancer].
    Mu DB; Wang SP; Yang WF; Fu Z; Chen XX; Sun XR; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):30-3. PubMed ID: 17575690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [18F]2-fluoro-2-deoxyglucose positron emission tomography/computed tomography in predicting radiation pneumonitis.
    Song H; Yu JM; Kong FM; Lu J; Bai T; Ma L; Fu Z
    Chin Med J (Engl); 2009 Jun; 122(11):1311-5. PubMed ID: 19567143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal uptake of 18F-FDG in the testis: an assessment by PET/CT.
    Kitajima K; Nakamoto Y; Senda M; Onishi Y; Okizuka H; Sugimura K
    Ann Nucl Med; 2007 Sep; 21(7):405-10. PubMed ID: 17876554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions.
    Yamaguchi T; Ueda O; Hara H; Sakai H; Kida T; Suzuki K; Adachi S; Ishii K
    Ann Nucl Med; 2009 Jan; 23(1):65-71. PubMed ID: 19205840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
    J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer.
    Guerra L; Niespolo R; Di Pisa G; Ippolito D; De Ponti E; Terrevazzi S; Bovo G; Sironi S; Gardani G; Messa C
    Abdom Imaging; 2011 Feb; 36(1):38-45. PubMed ID: 20033405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Need for standardization of 18F-FDG PET/CT for treatment response assessments.
    Boellaard R
    J Nucl Med; 2011 Dec; 52 Suppl 2():93S-100S. PubMed ID: 22144561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the pretreatment tumor sampling location correspond with metabolic activity on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy?
    Koolen BB; Elshof LE; Loo CE; Wesseling J; Vrancken Peeters MJ; Vogel WV; Rutgers EJ; Valdés Olmos RA
    Eur J Radiol; 2013 Dec; 82(12):2353-8. PubMed ID: 23998705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
    Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
    Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.
    Cheon GJ; Kim MS; Lee JA; Lee SY; Cho WH; Song WS; Koh JS; Yoo JY; Oh DH; Shin DS; Jeon DG
    J Nucl Med; 2009 Sep; 50(9):1435-40. PubMed ID: 19690035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlating metabolic and anatomic responses of primary lung cancers to radiotherapy by combined F-18 FDG PET-CT imaging.
    Wong CY; Schmidt J; Bong JS; Chundru S; Kestin L; Yan D; Grills I; Gaskill M; Cheng V; Martinez AA; Fink-Bennett D
    Radiat Oncol; 2007 May; 2():18. PubMed ID: 17521442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
    J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting standardized uptake value (SUV) of positron emission tomography (PET) imaging with l8F-FDG.
    Wiyaporn K; Tocharoenchai C; Pusuwan P; Ekjeen T; Leaungwutiwong S; Thanyarak S
    J Med Assoc Thai; 2010 Jan; 93(1):108-14. PubMed ID: 20196419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.
    Lyons K; Seghers V; Sorensen JI; Zhang W; Paldino MJ; Krishnamurthy R; Rohren EM
    AJR Am J Roentgenol; 2015 Nov; 205(5):1094-101. PubMed ID: 26496558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring of early response to neoadjuvant chemotherapy in breast cancer with (1)H MR spectroscopy: comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography.
    Tozaki M; Sakamoto M; Oyama Y; O'uchi T; Kawano N; Suzuki T; Yamashiro N; Ozaki S; Sakamoto N; Higa K; Abe S; Ogawa T; Fukuma E
    J Magn Reson Imaging; 2008 Aug; 28(2):420-7. PubMed ID: 18666159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring cancer treatment with PET/CT: does it make a difference?
    Weber WA; Figlin R
    J Nucl Med; 2007 Jan; 48 Suppl 1():36S-44S. PubMed ID: 17204719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single 20-second acquisition of deep-inspiration breath-hold PET/CT: clinical feasibility for lung cancer.
    Torizuka T; Tanizaki Y; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Ouchi Y
    J Nucl Med; 2009 Oct; 50(10):1579-84. PubMed ID: 19759111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastric GIST malignancy evaluated by 18FDG-PET as compared with EUS-FNA and endoscopic biopsy.
    Yamada M; Niwa Y; Matsuura T; Miyahara R; Ohashi A; Maeda O; Ando T; Ohmiya N; Itoh A; Hirooka Y; Goto H
    Scand J Gastroenterol; 2007 May; 42(5):633-41. PubMed ID: 17454885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.